Comerica Bank’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$204K Sell
2,096
-145
-6% -$12.4K ﹤0.01% 2282
2025
Q3
$159K Sell
2,241
-21
-0.9% -$1.4K ﹤0.01% 2428
2025
Q2
$135K Sell
2,262
-26
-1% -$1.43K ﹤0.01% 2493
2025
Q1
$120K Buy
2,288
+404
+21% +$22.7K ﹤0.01% 2506
2024
Q4
$104K Sell
1,884
-32
-2% -$1.68K ﹤0.01% 2564
2024
Q3
$96.3K Buy
1,916
+281
+17% +$13K ﹤0.01% 2591
2024
Q2
$71.8K Buy
1,635
+194
+13% +$8.25K ﹤0.01% 2654
2024
Q1
$63.4K Buy
1,441
+1,377
+2,152% +$60.9K ﹤0.01% 2689
2023
Q4
$3.04K Hold
64
﹤0.01% 3427
2023
Q3
$2.84K Sell
64
-3,416
-98% -$159K ﹤0.01% 3505
2023
Q2
$120 Buy
+3,480
New +$157K 0.01% 93

Other funds holding IRMD

Comerica Bank's IRMD Position: Q4 2025 in Review

Comerica Bank reduced its iRadimed (IRMD) stake by 6.5% in Q4 2025, selling an estimated $12.4K and leaving 2,096 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #2282.

Comerica Bank first reported a position in IRMD in Q2 2023 and has held it in 11 quarters since. 217 funds tracked by Wall St. Rank hold IRMD as of Q4 2025.

  • Comerica Bank held 2,096 shares of iRadimed worth $204K as of Q4 2025.
  • Comerica Bank sold 145 iRadimed shares in Q4 2025, an estimated $12.4K.
  • iRadimed made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2282 holding.
  • Comerica Bank first reported a position in iRadimed in Q2 2023 and has held it in 11 quarters since.
  • 217 funds tracked by Wall St. Rank held iRadimed as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.